Simon Farrell
SEC insider (Form 3/4/5 filer). CIK 0001965585. Director at Serina Therapeutics, Inc. (SER) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Jul 22, 2026. Located in HUNTSVILLE, AL.
Companies Simon Farrell has filed insider reports for
- Serina Therapeutics, Inc. (SER): Director
- Trevi Therapeutics, Inc. (TRVI): Officer, Chief Commercial Officer
Simon Farrell
CIK: 0001965585
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jul 22, 2026SER
Serina Therapeutics, Inc.
AwardDirectStock Option (right to buy)
30.5K shares- - Feb 19, 2026TRVI
Trevi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
160K shares- - May 31, 2025TRVI
Trevi Therapeutics, Inc.
AwardDirectPerformance Stock Option (right to buy)
72K shares- - Mar 10, 2025TRVI
Trevi Therapeutics, Inc.
SaleDirect77K shares at avg. $6.73$518K - Mar 10, 2025TRVI
Trevi Therapeutics, Inc.
SaleDirect4.4K shares at avg. $7.15$31K - Mar 10, 2025TRVI
Trevi Therapeutics, Inc.
AwardDirectPerformance Stock Option (right to buy)
38.4K shares- - Mar 10, 2025TRVI
Trevi Therapeutics, Inc.
ExerciseDirect63.8K shares at avg. $3.91$250K - Mar 10, 2025TRVI
Trevi Therapeutics, Inc.
ExerciseDirect31.3K shares at avg. $0.51$16K - Mar 10, 2025TRVI
Trevi Therapeutics, Inc.
ExerciseDirect17.5K shares at avg. $3.21$56K - Feb 18, 2025TRVI
Trevi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
225.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 22, 2026 |  SER Serina Therapeutics, Inc. | Award Stock Option (right to buy) | 30,500 | - | - | Direct |
| Feb 19, 2026 |  TRVI Trevi Therapeutics, Inc. | Award Stock Option (right to buy) | 160,000 | - | - | Direct |
| May 31, 2025 | TRVI Trevi Therapeutics, Inc. | Award Performance Stock Option (right to buy) | 72,000 | - | - | Direct |
| Mar 10, 2025 | TRVI Trevi Therapeutics, Inc. | Sale | 76,963 | $6.73 | $517,776 | Direct |
| Mar 10, 2025 | TRVI Trevi Therapeutics, Inc. | Sale | 4,350 | $7.15 | $31,102 | Direct |
| Mar 10, 2025 | TRVI Trevi Therapeutics, Inc. | Award Performance Stock Option (right to buy) | 38,400 | - | - | Direct |
| Mar 10, 2025 | TRVI Trevi Therapeutics, Inc. | Exercise | 63,813 | $3.91 | $249,509 | Direct |
| Mar 10, 2025 | TRVI Trevi Therapeutics, Inc. | Exercise | 31,250 | $0.51 | $15,969 | Direct |
| Mar 10, 2025 | TRVI Trevi Therapeutics, Inc. | Exercise | 17,500 | $3.21 | $56,175 | Direct |
| Feb 18, 2025 | TRVI Trevi Therapeutics, Inc. | Award Stock Option (right to buy) | 225,500 | - | - | Direct |
1-10 of 10 transactions